Lerch Till Dominic, Steppacher Simon Damian, Liechti Emanuel Francis, Tannast Moritz, Siebenrock Klaus Arno
Department of Orthopaedic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse, 3010, Bern, Switzerland.
Clin Orthop Relat Res. 2017 Apr;475(4):1154-1168. doi: 10.1007/s11999-016-5169-5.
Since its first description in 1984, periacetabular osteotomy (PAO) has become an accepted treatment for hip dysplasia. The 30-year survivorship with this procedure has not been reported. Because these patients are often very young at the time of surgery, long-term followup and identification of factors associated with poor outcome could help to improve patient selection.
QUESTIONS/PURPOSES: Looking at the initial group of patients with hip dysplasia undergoing PAO at the originator's institution, we asked: (1) What is the cumulative 30-year survival rate free from conversion to THA, radiographic progression of osteoarthritis, and/or a Merle d'Aubigné-Postel score < 15? (2) Did hip function improve and pain decrease? (3) Did radiographic osteoarthritis progress? (4) What are the factors associated with one or more of the three endpoints: THA, radiographic progression of osteoarthritis, and/or Merle d'Aubigné-Postel score < 15?
We retrospectively evaluated the first 63 patients (75 hips) who underwent PAO for hip dysplasia between 1984 and 1987. At that time, hip dysplasia was the only indication for PAO and no patients with acetabular retroversion, the second indication for a PAO performed today, were included. During that period, no other surgical treatment for hip dysplasia in patients with closed triradiate cartilage was performed. Advanced osteoarthritis (≥ Grade 2 according to Tönnis) was present preoperatively in 18 hips (24%) and 22 patients (23 hips [31%]) had previous femoral and/or acetabular surgery. Thirty-nine patients (42 hips [56%]) were converted to a THA and one patient (one hip [1%]) had hip fusion at latest followup. Two patients (three hips [4%]) died from a cause unrelated to surgery 6 and 16 years after surgery with an uneventful followup. From the remaining 21 patients (29 hips), the mean followup was 29 years (range, 27-32 years). Of those, five patients (six hips [8%]) did not return for the most recent followup and only a questionnaire was available. The cumulative survivorship of the hip according to Kaplan-Meier was calculated if any of the three endpoints, including conversion to THA, progression of osteoarthritis by at least one grade according to Tönnis, and/or a Merle d'Aubigné-Postel score < 15, occurred. Hip pain and function were assessed with Merle d'Aubigné-Postel score, Harris hip score, limp, and anterior and posterior impingement tests. Progression of radiographic osteoarthritis was assessed with Tönnis grades. A Cox regression model was used to calculate factors associated with the previously defined endpoints.
The cumulative survivorship free from conversion to THA, radiographic progression of osteoarthritis, and/or Merle d'Aubigné-Postel score < 15 was 29% (95% confidence interval, 17%-42%) at 30 years. No improvement was found for either the Merle d'Aubigné-Postel (15 ± 2 versus 16 ± 2, p = 0.144) or Harris hip score (83 ± 11 versus 85 ± 17, p = 0.602). The percentage of a positive anterior impingement test (39% versus 14%, p = 0.005) decreased at 30-year followup, whereas the percentage of a positive posterior impingement test (14% versus 3%, p = 0.592) did not decrease. The percentage of positive limp decreased from preoperatively 66% to 18% at 30-year followup (p < 0.001). Mean osteoarthritis grade (Tönnis) increased from preoperatively 0.8 ± 1 (0-3) to 2.1 ± 1 (0-3) at 30-year followup (p < 0.001). Ten factors associated with poor outcome defined as THA, radiographic progression of osteoarthritis, and/or Merle d'Aubigné-Postel score < 15 were found: preoperative age > 40 years (hazard ratio [HR] 4.3 [3.7-4.9]), a preoperative Merle d'Aubigné-Postel score < 15 (HR 4.1 [3.5-4.6]), a preoperative Harris hip score < 70 (HR 5.8 [5.2-6.4]), preoperative limp (HR 1.7 [1.4-1.9]), presence of a preoperative positive anterior impingement test (HR 3.6 [3.1-4.2]), presence of a preoperative positive posterior impingement test (HR 2.5 [1.7-3.2]), a preoperative internal rotation of < 20° (HR 4.3 [3.7-4.9]), a preoperative Tönnis Grade > 1 (HR 5.7 [5.0-6.4]), a postoperative anterior coverage > 27% (HR 3.2 [2.5-3.9]), and a postoperative acetabular retroversion (HR 4.8 [3.4-6.3]).
Thirty years postoperatively, 29% of hips undergoing PAO for hip dysplasia can be preserved, but more than 70% will develop progressive osteoarthritis, pain, and/or undergo THA. Periacetabular osteotomy is an effective technique to treat symptomatic hip dysplasia in selected and young patients with closed triradiate cartilage. Hips with advanced joint degeneration (osteoarthritis Tönnis Grade ≥ 2) should not be treated with PAO. Postoperative anterior acetabular overcoverage or postoperative acetabular retroversion were associated with decreased joint survival.
Level III, therapeutic study.
自1984年首次描述以来,髋臼周围截骨术(PAO)已成为治疗髋关节发育不良的一种公认方法。该手术30年的生存率尚未见报道。由于这些患者手术时往往非常年轻,长期随访以及识别与不良预后相关的因素有助于改善患者选择。
问题/目的:观察在发起机构接受PAO的最初一组髋关节发育不良患者,我们提出以下问题:(1)不进行全髋关节置换术(THA)转换、骨关节炎影像学进展和/或Merle d'Aubigné-Postel评分<15的30年累积生存率是多少?(2)髋关节功能是否改善且疼痛是否减轻?(3)影像学骨关节炎是否进展?(4)与三个终点之一或多个相关的因素是什么:THA、骨关节炎影像学进展和/或Merle d'Aubigné-Postel评分<15?
我们回顾性评估了1984年至1987年间因髋关节发育不良接受PAO的前63例患者(75髋)。当时,髋关节发育不良是PAO的唯一适应证,未纳入髋臼后倾患者(髋臼后倾是如今PAO的第二个适应证)。在此期间,未对闭合性三叶状软骨患者的髋关节发育不良进行其他手术治疗。术前18髋(24%)存在晚期骨关节炎(根据Tönnis分级≥2级),22例患者(23髋[31%])曾接受过股骨和/或髋臼手术。39例患者(42髋[56%])在最新随访时转换为THA,1例患者(1髋[1%])进行了髋关节融合。2例患者(3髋[4%])在术后6年和16年因与手术无关的原因死亡,随访过程顺利。在其余21例患者(29髋)中,平均随访时间为29年(范围27 - 32年)。其中,5例患者(6髋[8%])未返回进行最新随访,仅获得一份问卷。如果出现三个终点中的任何一个,包括转换为THA、根据Tönnis分级骨关节炎进展至少一级和/或Merle d'Aubigné-Postel评分<15,则根据Kaplan-Meier法计算髋关节的累积生存率。使用Merle d'Aubigné-Postel评分、Harris髋关节评分、跛行以及前后撞击试验评估髋关节疼痛和功能。使用Tönnis分级评估影像学骨关节炎的进展。使用Cox回归模型计算与先前定义的终点相关的因素。
30年时,不进行THA转换、骨关节炎影像学进展和/或Merle d'Aubigné-Postel评分<15的累积生存率为29%(95%置信区间,17% - 42%)。Merle d'Aubigné-Postel评分(15±2对16±2,p = 0.144)或Harris髋关节评分(83±11对85±17,p = 0.602)均未发现改善。在30年随访时,前撞击试验阳性百分比(39%对14%,p = 0.005)降低,而后撞击试验阳性百分比(14%对3%,p = 0.592)未降低。跛行阳性百分比从术前的66%降至30年随访时的18%(p < 0.001)。平均骨关节炎分级(Tönnis)从术前的0.8±1(0 - 3)增加到30年随访时的2.1±1(0 - 3)(p < 0.001)。发现与不良结局相关的10个因素,不良结局定义为THA、骨关节炎影像学进展和/或Merle d'Aubigné-Postel评分<15:术前年龄>40岁(风险比[HR] 4.3 [3.7 - 4.9])、术前Merle d'Aubigné-Postel评分<15(HR 4.1 [3.5 - 4.6])、术前Harris髋关节评分<70(HR 5.8 [5.2 - 6.4])、术前跛行(HR 1.7 [1.4 - 1.9])、术前前撞击试验阳性(HR 3.6 [3.1 - 4.2])、术前后撞击试验阳性(HR 2.5 [1.7 - 3.2])、术前内旋<20°(HR 4.3 [3.7 - 4.9])、术前Tönnis分级>1(HR 5.7 [5.0 - 6.4])、术后前覆盖>27%(HR 3.2 [2.5 - 3.9])以及术后髋臼后倾(HR 4.8 [3.4 - 6.3])。
术后30年,因髋关节发育不良接受PAO的髋关节中,29%可得以保留,但超过70%会出现进行性骨关节炎、疼痛和/或接受THA。髋臼周围截骨术是治疗有症状的髋关节发育不良且闭合性三叶状软骨的特定年轻患者的有效技术。存在晚期关节退变(骨关节炎Tönnis分级≥2级)的髋关节不应采用PAO治疗。术后髋臼前过度覆盖或术后髋臼后倾与关节生存率降低相关。
III级,治疗性研究。